Kevin Bell Quoted in Natural Products Insider Article on FDA’s Final Guidance Regarding NAC

Kevin Bell, co-chair of AGG’s Intellectual Property practice and Dietary Supplements industry team, was quoted in a Natural Products Insider article titled “FDA Issues Final ‘Enforcement Discretion’ Guidance on NAC.”

According to FDA’s final guidance, which was entered into the federal register on August 2, 2022, the agency plans “to exercise enforcement discretion” concerning the distribution and sale of certain products labeled as dietary supplements and containing NAC (N-acetyl-L-cysteine).

“Industry, and especially large online retailers, should now have the level of clarity and comfort from the agency to go back to the business of selling NAC,” said Kevin, who serves as counsel to the Natural Products Association.

To read the full article, please click here.